Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Competitive Landscape Professional Research Report 2024

Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Competitive Landscape Professional Research Report 2024



Research Summary

Mesenchymal stem cells (MSCs) and exosomes are key elements in the field of regenerative medicine and hold promise for diagnostics and therapies. MSCs are a type of adult stem cell that can be derived from various sources, such as bone marrow, adipose tissue, and umbilical cord, and possess the ability to differentiate into multiple cell types including bone, cartilage, and fat cells. These cells also exhibit immunomodulatory and anti-inflammatory properties, making them attractive for therapeutic applications. Exosomes, on the other hand, are small vesicles released by cells that contain various bioactive molecules, including proteins, nucleic acids, and microRNAs. They play a crucial role in intercellular communication and have shown potential as therapeutic vehicles due to their ability to transfer critical signaling molecules to target cells. In diagnostics, both MSCs and exosomes offer non-invasive approaches for assessing disease progression, predicting treatment response, and monitoring therapeutic outcomes. These technologies are being actively researched and developed for a wide range of conditions, including degenerative diseases, autoimmune disorders, tissue regeneration, and cancer. The field of MSC and exosome diagnostics and therapies holds great promise for advancing personalized medicine and improving patient outcomes.

According to DIResearch's in-depth investigation and research, the global Msenchymal Stem Cell and Exosome Diagnostics and Therapies market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Msenchymal Stem Cell and Exosome Diagnostics and Therapies include Tianjin Angsai Cell Genetic Engineering, Qingdao Aoke Biological Development, Beijing SH biotechnology, Shanghai Aisar Biotechnology, Beijing Beilai Biotechnology, Jiuzhitang Meike (Beijing) Cell Technology, Beijing Han's United Biotechnology, Bosheng Excellence Biotechnology (Beijing) , Cellular Biomedicine Group, Guangzhou Celera Stem Cell Technology, Stem Med, CryoCord, Cytopeutics Sdn Bhd, Stempeutics Research, Asian Institute of Gastroenterology etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Msenchymal Stem Cell and Exosome Diagnostics and Therapies. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Msenchymal Stem Cell and Exosome Diagnostics and Therapies market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Msenchymal Stem Cell and Exosome Diagnostics and Therapies market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Msenchymal Stem Cell and Exosome Diagnostics and Therapies industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Msenchymal Stem Cell and Exosome Diagnostics and Therapies Include:

Tianjin Angsai Cell Genetic Engineering

Qingdao Aoke Biological Development

Beijing SH biotechnology

Shanghai Aisar Biotechnology

Beijing Beilai Biotechnology

Jiuzhitang Meike (Beijing) Cell Technology

Beijing Han's United Biotechnology

Bosheng Excellence Biotechnology (Beijing)

Cellular Biomedicine Group

Guangzhou Celera Stem Cell Technology

Stem Med

CryoCord

Cytopeutics Sdn Bhd

Stempeutics Research

Asian Institute of Gastroenterology

Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Segment Include:

Autologous MSC Therapy

Allogeneic MSC Therapy

Adipose-Derived MSC Therapy

Bone Marrow-Derived MSC Therapy

Other

Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Application Include:

Diagnostics

Therapies

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Industry PESTEL Analysis

Chapter 3: Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Industry Porter’s Five Forces Analysis

Chapter 4: Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Regional Market Size and Forecast Analysis

Chapter 5: Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Msenchymal Stem Cell and Exosome Diagnostics and Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Msenchymal Stem Cell and Exosome Diagnostics and Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources


1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Overview
1.1 Product Definition and Statistical Scope
1.2 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product by Type
1.2.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Type, 2023 VS 2024 VS 2030
1.2.2 Autologous MSC Therapy
1.2.3 Allogeneic MSC Therapy
1.2.4 Adipose-Derived MSC Therapy
1.2.5 Bone Marrow-Derived MSC Therapy
1.2.6 Other
1.3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product by Application
1.3.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Application, 2023 VS 2024 VS 2030
1.3.2 Diagnostics
1.3.3 Therapies
1.4 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Revenue Analysis (2019-2030)
1.5 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Development Status and Trends
1.5.1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Industry Development Status Analysis
1.5.2 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Industry Development Trends Analysis
2 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Analysis by Regions
4.1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Overall Market: 2023 VS 2024 VS 2030
4.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue and Forecast Analysis (2019-2030)
4.2.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue and Market Share by Region (2019-2024)
4.2.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Forecast by Region (2025-2030)
5 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Type and Application
5.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Type
5.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Application
6 North America
6.1 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size and Growth Rate Analysis (2019-2030)
6.2 North America Key Manufacturers Analysis
6.3 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Type
6.4 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Application
6.5 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size and Growth Rate Analysis (2019-2030)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Type
7.4 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Application
7.5 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size and Growth Rate Analysis (2019-2030)
8.2 China Key Manufacturers Analysis
8.3 China Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Type
8.4 China Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Application
9 APAC (excl. China)
9.1 APAC (excl. China) Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size and Growth Rate Analysis (2019-2030)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Type
9.4 APAC (excl. China) Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Application
9.5 APAC (excl. China) Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Indonesia
9.5.6 Vietnam
9.5.7 Malaysia
9.5.8 Thailand
10 Latin America
10.1 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size and Growth Rate Analysis (2019-2030)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Type
10.4 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Application
10.5 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country
10.5.1 Mecixo
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size and Growth Rate Analysis (2019-2030)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Type
11.4 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Application
11.5 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Market Competition by Manufacturers
12.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Revenue by Key Manufacturers (2020-2024)
12.2 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Competitive Landscape Analysis and Market Dynamic
12.2.1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Tianjin Angsai Cell Genetic Engineering
13.1.1 Tianjin Angsai Cell Genetic Engineering Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Tianjin Angsai Cell Genetic Engineering Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
13.1.3 Tianjin Angsai Cell Genetic Engineering Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.2 Qingdao Aoke Biological Development
13.2.1 Qingdao Aoke Biological Development Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Qingdao Aoke Biological Development Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
13.2.3 Qingdao Aoke Biological Development Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.3 Beijing SH biotechnology
13.3.1 Beijing SH biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Beijing SH biotechnology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
13.3.3 Beijing SH biotechnology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.4 Shanghai Aisar Biotechnology
13.4.1 Shanghai Aisar Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 Shanghai Aisar Biotechnology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
13.4.3 Shanghai Aisar Biotechnology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.5 Beijing Beilai Biotechnology
13.5.1 Beijing Beilai Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Beijing Beilai Biotechnology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
13.5.3 Beijing Beilai Biotechnology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.6 Jiuzhitang Meike (Beijing) Cell Technology
13.6.1 Jiuzhitang Meike (Beijing) Cell Technology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Jiuzhitang Meike (Beijing) Cell Technology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
13.6.3 Jiuzhitang Meike (Beijing) Cell Technology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.7 Beijing Han's United Biotechnology
13.7.1 Beijing Han's United Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Beijing Han's United Biotechnology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
13.7.3 Beijing Han's United Biotechnology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.8 Bosheng Excellence Biotechnology (Beijing)
13.8.1 Bosheng Excellence Biotechnology (Beijing) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 Bosheng Excellence Biotechnology (Beijing) Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
13.8.3 Bosheng Excellence Biotechnology (Beijing) Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.9 Cellular Biomedicine Group
13.9.1 Cellular Biomedicine Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
13.9.3 Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.10 Guangzhou Celera Stem Cell Technology
13.10.1 Guangzhou Celera Stem Cell Technology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 Guangzhou Celera Stem Cell Technology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
13.10.3 Guangzhou Celera Stem Cell Technology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.11 Stem Med
13.11.1 Stem Med Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.11.2 Stem Med Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
13.11.3 Stem Med Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.12 CryoCord
13.12.1 CryoCord Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.12.2 CryoCord Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
13.12.3 CryoCord Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.13 Cytopeutics Sdn Bhd
13.13.1 Cytopeutics Sdn Bhd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.13.2 Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
13.13.3 Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.14 Stempeutics Research
13.14.1 Stempeutics Research Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.14.2 Stempeutics Research Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
13.14.3 Stempeutics Research Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.15 Asian Institute of Gastroenterology
13.15.1 Asian Institute of Gastroenterology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.15.2 Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
13.15.3 Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
14 Industry Chain Analysis
14.1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Industry Chain Analysis
14.2 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Industry Raw Material and Suppliers Analysis
14.2.1 Upstream Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Typical Downstream Customers
14.4 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings